Evidence map›Paper›PMID 40487657›Full record

ArticleActa pharmaceutica Sinica. B2025

Marine-derived new peptaibols with antibacterial activities by targeting bacterial membrane phospholipids.

Shang Chen, Dong Liu, Liyang Wang, Aili Fan, Mengyue Wu, Ning Xu, Kui Zhu, Wenhan Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Genome-Guided Metabolomic Profiling of Peptaibol-ProducingInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shang ChenState Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China.
Dong LiuState Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China.
Liyang WangNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Aili FanState Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China.
Mengyue WuState Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China.
Ning XuThe Technology Center for Protein Sciences, Tsinghua University, Beijing 100084, China.
Kui ZhuNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Wenhan LinState Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is spreading at a faster rate than new antibiotic agents applied for clinical remedies. It is an urgent need to discover potential compounds to combat multidrug-resistant (MDR) bacteria. Marine fungi offer a promising avenue for mining antibiotic-like molecules with chemical diversity. To discover structurally novel and antibiotic metabolites, we screened the in-house marine fungus genome library and found a fungus

Indexed as

AntibioticBactericidal activityMarine fungusNatural productNRPSPeptaibolPhosphatidylglycerolPhospholipid

Identifiers

PMID40487657
PMCPMC12145052

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.